Dollars for Profs

Dig Into University Researchers' Outside Income and Conflicts of Interest

Published Dec. 6, 2019

This database was last updated in December 2019 and should only be used as a historical snapshot. There may be new or amended records not reflected here.

Financial doc
Filing Type

Conflict of Interest

Institutions must file significant disclosures to the National Institutes of Health if they determine financial relationships could affect the design, conduct or reporting of the NIH-funded research. The NIH provided us with their entire financial conflict of interest database, with filings from 2012 through 2019.

Should you be removed from our database? Contact us at [email protected]. Read more below.

Levi Garraway

Harvard Medical School, Department: Biology

Should you be removed from our database? Contact us at [email protected]. Read more below.

Disclosed Conflict of Interest with

Foundation Medicine, Inc.

Disclosed Value
Listed Reason
Equity Interest - Publicly traded entity (e.g., stock, stock option, or other ownership interest)

Foundation Medicine is focused on the treatment of solid tumors and hematologic cancers, and on providing comprehensive genomic profiles to oncologists to help them match their patients to targeted therapies. The company collaborates with drug developers and cancer researchers to identify novel targets and assist in the development of targeted cancer therapies and active clinical trials. Additionally, the company leverages its molecular information platform to inform drug development and enable precision medicine.

Listed Research Project
Dissecting response and resistance to CDK4/6 inhibition in ER+ breast cancer

Since breast cancer is the leading cause of cancer-related deaths among women, the recent development of highly specific cell cycle inhibitors is a potentially exciting therapeutic breakthrough. Unfortunately, clinical predictors of sensitivity an resistance to these targeted agents are not well characterized. By investigating the mechanistic determinants of response to cell cycle inhibition, our proposal will ultimately inform more effective use of cell cycle inhibitors and preserve the efficacy of these drugs in the treatment of breast cancer patients.

Filed on April 01, 2015.

Tell us what you know about Levi Garraway's disclosure

We're still reporting about conflicts of interest. Is there something you'd like to tell us about this disclosure?

Name Institution Type Company Disclosed Value
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine >$600,000
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine $80,000 - $99,999
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine >$600,000
Levi Garraway Harvard Medical School Conflict of Interest Foundation Medicine, Inc. $80,000 - $99,999
Levi Garraway Massachusetts General Hospital Conflict of Interest Foundation Medicine $80,000 - $99,999
Levi Garraway Massachusetts General Hospital Conflict of Interest Foundation Medicine Value cannot be readily determined
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine $60,000 - $79,999
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine $60,000 - $79,999
Levi Garraway Dana Farber Cancer Inst Conflict of Interest Foundation Medicine >$600,000
If you see an error in the database or a reason we should not disclose a record, please contact us at [email protected] and we'll evaluate it on a case-by-case basis.
Sources: National Institutes of Health, public records requests filed at multiple public state universities

Notes: When a more specific filing date is not available for an individual financial disclosure or conflict of interest form, we use the year the form was filed. If the year was not disclosed, we report the range of years covered by our public records requests. In a few cases, a start date was provided instead of a filing date. In those cases, we use the start date instead.

Fewer than 10% of records from the University of Florida and fewer than 1% of records from the University of Texas system were removed because they did not contain enough information.

ProPublica obtained additional financial disclosures and conflict of interest forms that we have not yet digitized and added to the database. You can download those disclosures in the ProPublica Data Store.

Close Comment Creative Commons Donate Email Facebook Mobile Phone Podcast Print RSS Search Search Twitter WhatsApp
Current site Current page